Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer

Published:2016-07-05 Issue:20 Volume:122 Page:3191-3198
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vijayvergia Namrata¹,Li Tianyu²,Wong Yu-Ning¹,Hall Michael J.¹,Cohen Steven J.¹,Dotan Efrat¹

Affiliation:

1. Department of Hematology and Oncology; Fox Chase Cancer Center, Temple University Health System; Philadelphia Pennsylvania

2. Department of Biostatistics; Fox Chase Cancer Center, Temple University Health System; Philadelphia Pennsylvania

Funder

National Cancer Institute

American Cancer Society

Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. CALGB/SWOG 80405: phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC) [abstract];Venook;ASCO Annual Meeting Proceedings.,2014

2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet.,2000

3. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;Gramont;J Clin Oncol.,2000

4. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol.,2004

5. Metastatic colon cancer, version 3.2013: featured updates to the NCCN guidelines;Benson;J Natl Compr Canc Netw.,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age May Be an Important Factor Affecting Neoadjuvant Chemotherapy in Patients With Locally Advanced Colon Cancer;Journal of Clinical Oncology;2024-07-24

2. Guidance for Treating the Older Adults with Colorectal Cancer;Current Treatment Options in Oncology;2023-04-13

3. Oncogeriatric Developments;Gerontology;2023

4. Assessing Oncologists’ Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data;JNCI Cancer Spectrum;2022-09-23

5. Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies;Drugs & Aging;2021-06-18